Biomedical device company Cellnovo, which is developing a mobile diabetes management system, is one step closer to taking its product to market after securing £30 million in a fundraising.
A medical device company focussing on the development and commercialisation of innovative orthopaedic medical devices for the spine and trauma markets has joined AIM.